Pharma & Healthcare
Global Irritable Bowel Syndrome (IBS) Market Research Report 2026
- Jan 17, 26
- ID: 687802
- Pages: 103
- Figures: 105
- Views: 9
This report delivers a comprehensive overview of the global Irritable Bowel Syndrome (IBS) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Irritable Bowel Syndrome (IBS). The Irritable Bowel Syndrome (IBS) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Irritable Bowel Syndrome (IBS) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Irritable Bowel Syndrome (IBS) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Bausch Health
Allergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals
Segment by Type
IBS-D Drug
IBS-C Drug
Others
Segment by Application
Women
Men
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Irritable Bowel Syndrome (IBS) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Irritable Bowel Syndrome (IBS) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Irritable Bowel Syndrome (IBS) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Bausch Health
Allergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals
Segment by Type
IBS-D Drug
IBS-C Drug
Others
Segment by Application
Women
Men
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Irritable Bowel Syndrome (IBS) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 IBS-D Drug
1.2.3 IBS-C Drug
1.2.4 Others
1.3 Market by Application
1.3.1 Global Irritable Bowel Syndrome (IBS) Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Women
1.3.3 Men
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Irritable Bowel Syndrome (IBS) Market Perspective (2021–2032)
2.2 Global Irritable Bowel Syndrome (IBS) Growth Trends by Region
2.2.1 Global Irritable Bowel Syndrome (IBS) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Irritable Bowel Syndrome (IBS) Historic Market Size by Region (2021–2026)
2.2.3 Irritable Bowel Syndrome (IBS) Forecasted Market Size by Region (2027–2032)
2.3 Irritable Bowel Syndrome (IBS) Market Dynamics
2.3.1 Irritable Bowel Syndrome (IBS) Industry Trends
2.3.2 Irritable Bowel Syndrome (IBS) Market Drivers
2.3.3 Irritable Bowel Syndrome (IBS) Market Challenges
2.3.4 Irritable Bowel Syndrome (IBS) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Irritable Bowel Syndrome (IBS) Players by Revenue
3.1.1 Global Top Irritable Bowel Syndrome (IBS) Players by Revenue (2021–2026)
3.1.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2021–2026)
3.2 Global Top Irritable Bowel Syndrome (IBS) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Irritable Bowel Syndrome (IBS) Revenue
3.4 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio
3.4.1 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome (IBS) Revenue in 2025
3.5 Global Key Players of Irritable Bowel Syndrome (IBS) Head Offices and Areas Served
3.6 Global Key Players of Irritable Bowel Syndrome (IBS), Products and Applications
3.7 Global Key Players of Irritable Bowel Syndrome (IBS), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Irritable Bowel Syndrome (IBS) Breakdown Data by Type
4.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Type (2021–2026)
4.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (2027–2032)
5 Irritable Bowel Syndrome (IBS) Breakdown Data by Application
5.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Application (2021–2026)
5.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Irritable Bowel Syndrome (IBS) Market Size (2021–2032)
6.2 North America Irritable Bowel Syndrome (IBS) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2021–2026)
6.4 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) Market Size (2021–2032)
7.2 Europe Irritable Bowel Syndrome (IBS) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2021–2026)
7.4 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size (2021–2032)
8.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (2021–2026)
8.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Irritable Bowel Syndrome (IBS) Market Size (2021–2032)
9.2 Latin America Irritable Bowel Syndrome (IBS) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2021–2026)
9.4 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size (2021–2032)
10.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2021–2026)
10.4 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Details
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Introduction
11.1.4 Bausch Health Revenue in Irritable Bowel Syndrome (IBS) Business (2021–2026)
11.1.5 Bausch Health Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Irritable Bowel Syndrome (IBS) Introduction
11.2.4 Allergan Revenue in Irritable Bowel Syndrome (IBS) Business (2021–2026)
11.2.5 Allergan Recent Development
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Irritable Bowel Syndrome (IBS) Introduction
11.3.4 Takeda Revenue in Irritable Bowel Syndrome (IBS) Business (2021–2026)
11.3.5 Takeda Recent Development
11.4 Sucampo Pharmaceuticals (Mallinckrodt)
11.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Company Details
11.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
11.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Introduction
11.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Revenue in Irritable Bowel Syndrome (IBS) Business (2021–2026)
11.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Development
11.5 Sebela Pharmaceuticals Inc
11.5.1 Sebela Pharmaceuticals Inc Company Details
11.5.2 Sebela Pharmaceuticals Inc Business Overview
11.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Introduction
11.5.4 Sebela Pharmaceuticals Inc Revenue in Irritable Bowel Syndrome (IBS) Business (2021–2026)
11.5.5 Sebela Pharmaceuticals Inc Recent Development
11.6 Astellas Pharmaceuticals
11.6.1 Astellas Pharmaceuticals Company Details
11.6.2 Astellas Pharmaceuticals Business Overview
11.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Introduction
11.6.4 Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2021–2026)
11.6.5 Astellas Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 IBS-D Drug
1.2.3 IBS-C Drug
1.2.4 Others
1.3 Market by Application
1.3.1 Global Irritable Bowel Syndrome (IBS) Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Women
1.3.3 Men
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Irritable Bowel Syndrome (IBS) Market Perspective (2021–2032)
2.2 Global Irritable Bowel Syndrome (IBS) Growth Trends by Region
2.2.1 Global Irritable Bowel Syndrome (IBS) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Irritable Bowel Syndrome (IBS) Historic Market Size by Region (2021–2026)
2.2.3 Irritable Bowel Syndrome (IBS) Forecasted Market Size by Region (2027–2032)
2.3 Irritable Bowel Syndrome (IBS) Market Dynamics
2.3.1 Irritable Bowel Syndrome (IBS) Industry Trends
2.3.2 Irritable Bowel Syndrome (IBS) Market Drivers
2.3.3 Irritable Bowel Syndrome (IBS) Market Challenges
2.3.4 Irritable Bowel Syndrome (IBS) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Irritable Bowel Syndrome (IBS) Players by Revenue
3.1.1 Global Top Irritable Bowel Syndrome (IBS) Players by Revenue (2021–2026)
3.1.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2021–2026)
3.2 Global Top Irritable Bowel Syndrome (IBS) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Irritable Bowel Syndrome (IBS) Revenue
3.4 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio
3.4.1 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome (IBS) Revenue in 2025
3.5 Global Key Players of Irritable Bowel Syndrome (IBS) Head Offices and Areas Served
3.6 Global Key Players of Irritable Bowel Syndrome (IBS), Products and Applications
3.7 Global Key Players of Irritable Bowel Syndrome (IBS), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Irritable Bowel Syndrome (IBS) Breakdown Data by Type
4.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Type (2021–2026)
4.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (2027–2032)
5 Irritable Bowel Syndrome (IBS) Breakdown Data by Application
5.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Application (2021–2026)
5.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Irritable Bowel Syndrome (IBS) Market Size (2021–2032)
6.2 North America Irritable Bowel Syndrome (IBS) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2021–2026)
6.4 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) Market Size (2021–2032)
7.2 Europe Irritable Bowel Syndrome (IBS) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2021–2026)
7.4 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size (2021–2032)
8.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (2021–2026)
8.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Irritable Bowel Syndrome (IBS) Market Size (2021–2032)
9.2 Latin America Irritable Bowel Syndrome (IBS) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2021–2026)
9.4 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size (2021–2032)
10.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2021–2026)
10.4 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Details
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Introduction
11.1.4 Bausch Health Revenue in Irritable Bowel Syndrome (IBS) Business (2021–2026)
11.1.5 Bausch Health Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Irritable Bowel Syndrome (IBS) Introduction
11.2.4 Allergan Revenue in Irritable Bowel Syndrome (IBS) Business (2021–2026)
11.2.5 Allergan Recent Development
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Irritable Bowel Syndrome (IBS) Introduction
11.3.4 Takeda Revenue in Irritable Bowel Syndrome (IBS) Business (2021–2026)
11.3.5 Takeda Recent Development
11.4 Sucampo Pharmaceuticals (Mallinckrodt)
11.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Company Details
11.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
11.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Introduction
11.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Revenue in Irritable Bowel Syndrome (IBS) Business (2021–2026)
11.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Development
11.5 Sebela Pharmaceuticals Inc
11.5.1 Sebela Pharmaceuticals Inc Company Details
11.5.2 Sebela Pharmaceuticals Inc Business Overview
11.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Introduction
11.5.4 Sebela Pharmaceuticals Inc Revenue in Irritable Bowel Syndrome (IBS) Business (2021–2026)
11.5.5 Sebela Pharmaceuticals Inc Recent Development
11.6 Astellas Pharmaceuticals
11.6.1 Astellas Pharmaceuticals Company Details
11.6.2 Astellas Pharmaceuticals Business Overview
11.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Introduction
11.6.4 Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2021–2026)
11.6.5 Astellas Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of IBS-D Drug
Table 3. Key Players of IBS-C Drug
Table 4. Key Players of Others
Table 5. Global Irritable Bowel Syndrome (IBS) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Irritable Bowel Syndrome (IBS) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Irritable Bowel Syndrome (IBS) Market Size by Region (US$ Million), 2021–2026
Table 8. Global Irritable Bowel Syndrome (IBS) Market Share by Region (2021–2026)
Table 9. Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Irritable Bowel Syndrome (IBS) Market Share by Region (2027–2032)
Table 11. Irritable Bowel Syndrome (IBS) Market Trends
Table 12. Irritable Bowel Syndrome (IBS) Market Drivers
Table 13. Irritable Bowel Syndrome (IBS) Market Challenges
Table 14. Irritable Bowel Syndrome (IBS) Market Restraints
Table 15. Global Irritable Bowel Syndrome (IBS) Revenue by Players (US$ Million), 2021–2026
Table 16. Global Irritable Bowel Syndrome (IBS) Market Share by Players (2021–2026)
Table 17. Global Top Irritable Bowel Syndrome (IBS) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Irritable Bowel Syndrome (IBS) Revenue, 2025
Table 18. Ranking of Global Top Irritable Bowel Syndrome (IBS) Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Irritable Bowel Syndrome (IBS) Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Irritable Bowel Syndrome (IBS), Headquarters and Area Served
Table 21. Global Key Players of Irritable Bowel Syndrome (IBS), Products and Applications
Table 22. Global Key Players of Irritable Bowel Syndrome (IBS), Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Irritable Bowel Syndrome (IBS) Market Size by Type (US$ Million), 2021–2026
Table 25. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2021–2026)
Table 26. Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2027–2032)
Table 28. Global Irritable Bowel Syndrome (IBS) Market Size by Application (US$ Million), 2021–2026
Table 29. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2021–2026)
Table 30. Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2027–2032)
Table 32. North America Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2021–2026
Table 34. North America Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2027–2032
Table 47. Bausch Health Company Details
Table 48. Bausch Health Business Overview
Table 49. Bausch Health Irritable Bowel Syndrome (IBS) Product
Table 50. Bausch Health Revenue in Irritable Bowel Syndrome (IBS) Business (US$ Million), 2021–2026
Table 51. Bausch Health Recent Development
Table 52. Allergan Company Details
Table 53. Allergan Business Overview
Table 54. Allergan Irritable Bowel Syndrome (IBS) Product
Table 55. Allergan Revenue in Irritable Bowel Syndrome (IBS) Business (US$ Million), 2021–2026
Table 56. Allergan Recent Development
Table 57. Takeda Company Details
Table 58. Takeda Business Overview
Table 59. Takeda Irritable Bowel Syndrome (IBS) Product
Table 60. Takeda Revenue in Irritable Bowel Syndrome (IBS) Business (US$ Million), 2021–2026
Table 61. Takeda Recent Development
Table 62. Sucampo Pharmaceuticals (Mallinckrodt) Company Details
Table 63. Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
Table 64. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product
Table 65. Sucampo Pharmaceuticals (Mallinckrodt) Revenue in Irritable Bowel Syndrome (IBS) Business (US$ Million), 2021–2026
Table 66. Sucampo Pharmaceuticals (Mallinckrodt) Recent Development
Table 67. Sebela Pharmaceuticals Inc Company Details
Table 68. Sebela Pharmaceuticals Inc Business Overview
Table 69. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product
Table 70. Sebela Pharmaceuticals Inc Revenue in Irritable Bowel Syndrome (IBS) Business (US$ Million), 2021–2026
Table 71. Sebela Pharmaceuticals Inc Recent Development
Table 72. Astellas Pharmaceuticals Company Details
Table 73. Astellas Pharmaceuticals Business Overview
Table 74. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product
Table 75. Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (US$ Million), 2021–2026
Table 76. Astellas Pharmaceuticals Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
Table 80. Authors List of This Report
List of Figures
Figure 1. Irritable Bowel Syndrome (IBS) Picture
Figure 2. Global Irritable Bowel Syndrome (IBS) Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Irritable Bowel Syndrome (IBS) Market Share by Type: 2025 vs 2032
Figure 4. IBS-D Drug Features
Figure 5. IBS-C Drug Features
Figure 6. Others Features
Figure 7. Global Irritable Bowel Syndrome (IBS) Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Irritable Bowel Syndrome (IBS) Market Share by Application: 2025 vs 2032
Figure 9. Women Case Studies
Figure 10. Men Case Studies
Figure 11. Irritable Bowel Syndrome (IBS) Report Years Considered
Figure 12. Global Irritable Bowel Syndrome (IBS) Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Irritable Bowel Syndrome (IBS) Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Irritable Bowel Syndrome (IBS) Market Share by Region: 2025 vs 2032
Figure 15. Global Irritable Bowel Syndrome (IBS) Market Share by Players in 2025
Figure 16. Global Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Irritable Bowel Syndrome (IBS) Revenue in 2025
Figure 18. North America Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Irritable Bowel Syndrome (IBS) Market Share by Country (2021–2032)
Figure 20. United States Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Irritable Bowel Syndrome (IBS) Market Share by Country (2021–2032)
Figure 24. Germany Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Share by Region (2021–2032)
Figure 32. China Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Irritable Bowel Syndrome (IBS) Market Share by Country (2021–2032)
Figure 40. Mexico Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Share by Country (2021–2032)
Figure 44. Israel Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Bausch Health Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2021–2026)
Figure 48. Allergan Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2021–2026)
Figure 49. Takeda Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2021–2026)
Figure 50. Sucampo Pharmaceuticals (Mallinckrodt) Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2021–2026)
Figure 51. Sebela Pharmaceuticals Inc Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2021–2026)
Figure 52. Astellas Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2021–2026)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Table 1. Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of IBS-D Drug
Table 3. Key Players of IBS-C Drug
Table 4. Key Players of Others
Table 5. Global Irritable Bowel Syndrome (IBS) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Irritable Bowel Syndrome (IBS) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Irritable Bowel Syndrome (IBS) Market Size by Region (US$ Million), 2021–2026
Table 8. Global Irritable Bowel Syndrome (IBS) Market Share by Region (2021–2026)
Table 9. Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Irritable Bowel Syndrome (IBS) Market Share by Region (2027–2032)
Table 11. Irritable Bowel Syndrome (IBS) Market Trends
Table 12. Irritable Bowel Syndrome (IBS) Market Drivers
Table 13. Irritable Bowel Syndrome (IBS) Market Challenges
Table 14. Irritable Bowel Syndrome (IBS) Market Restraints
Table 15. Global Irritable Bowel Syndrome (IBS) Revenue by Players (US$ Million), 2021–2026
Table 16. Global Irritable Bowel Syndrome (IBS) Market Share by Players (2021–2026)
Table 17. Global Top Irritable Bowel Syndrome (IBS) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Irritable Bowel Syndrome (IBS) Revenue, 2025
Table 18. Ranking of Global Top Irritable Bowel Syndrome (IBS) Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Irritable Bowel Syndrome (IBS) Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Irritable Bowel Syndrome (IBS), Headquarters and Area Served
Table 21. Global Key Players of Irritable Bowel Syndrome (IBS), Products and Applications
Table 22. Global Key Players of Irritable Bowel Syndrome (IBS), Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Irritable Bowel Syndrome (IBS) Market Size by Type (US$ Million), 2021–2026
Table 25. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2021–2026)
Table 26. Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2027–2032)
Table 28. Global Irritable Bowel Syndrome (IBS) Market Size by Application (US$ Million), 2021–2026
Table 29. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2021–2026)
Table 30. Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2027–2032)
Table 32. North America Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2021–2026
Table 34. North America Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (US$ Million), 2027–2032
Table 47. Bausch Health Company Details
Table 48. Bausch Health Business Overview
Table 49. Bausch Health Irritable Bowel Syndrome (IBS) Product
Table 50. Bausch Health Revenue in Irritable Bowel Syndrome (IBS) Business (US$ Million), 2021–2026
Table 51. Bausch Health Recent Development
Table 52. Allergan Company Details
Table 53. Allergan Business Overview
Table 54. Allergan Irritable Bowel Syndrome (IBS) Product
Table 55. Allergan Revenue in Irritable Bowel Syndrome (IBS) Business (US$ Million), 2021–2026
Table 56. Allergan Recent Development
Table 57. Takeda Company Details
Table 58. Takeda Business Overview
Table 59. Takeda Irritable Bowel Syndrome (IBS) Product
Table 60. Takeda Revenue in Irritable Bowel Syndrome (IBS) Business (US$ Million), 2021–2026
Table 61. Takeda Recent Development
Table 62. Sucampo Pharmaceuticals (Mallinckrodt) Company Details
Table 63. Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
Table 64. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product
Table 65. Sucampo Pharmaceuticals (Mallinckrodt) Revenue in Irritable Bowel Syndrome (IBS) Business (US$ Million), 2021–2026
Table 66. Sucampo Pharmaceuticals (Mallinckrodt) Recent Development
Table 67. Sebela Pharmaceuticals Inc Company Details
Table 68. Sebela Pharmaceuticals Inc Business Overview
Table 69. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product
Table 70. Sebela Pharmaceuticals Inc Revenue in Irritable Bowel Syndrome (IBS) Business (US$ Million), 2021–2026
Table 71. Sebela Pharmaceuticals Inc Recent Development
Table 72. Astellas Pharmaceuticals Company Details
Table 73. Astellas Pharmaceuticals Business Overview
Table 74. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product
Table 75. Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (US$ Million), 2021–2026
Table 76. Astellas Pharmaceuticals Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
Table 80. Authors List of This Report
List of Figures
Figure 1. Irritable Bowel Syndrome (IBS) Picture
Figure 2. Global Irritable Bowel Syndrome (IBS) Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Irritable Bowel Syndrome (IBS) Market Share by Type: 2025 vs 2032
Figure 4. IBS-D Drug Features
Figure 5. IBS-C Drug Features
Figure 6. Others Features
Figure 7. Global Irritable Bowel Syndrome (IBS) Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Irritable Bowel Syndrome (IBS) Market Share by Application: 2025 vs 2032
Figure 9. Women Case Studies
Figure 10. Men Case Studies
Figure 11. Irritable Bowel Syndrome (IBS) Report Years Considered
Figure 12. Global Irritable Bowel Syndrome (IBS) Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Irritable Bowel Syndrome (IBS) Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Irritable Bowel Syndrome (IBS) Market Share by Region: 2025 vs 2032
Figure 15. Global Irritable Bowel Syndrome (IBS) Market Share by Players in 2025
Figure 16. Global Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Irritable Bowel Syndrome (IBS) Revenue in 2025
Figure 18. North America Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Irritable Bowel Syndrome (IBS) Market Share by Country (2021–2032)
Figure 20. United States Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Irritable Bowel Syndrome (IBS) Market Share by Country (2021–2032)
Figure 24. Germany Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Share by Region (2021–2032)
Figure 32. China Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Irritable Bowel Syndrome (IBS) Market Share by Country (2021–2032)
Figure 40. Mexico Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Share by Country (2021–2032)
Figure 44. Israel Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Irritable Bowel Syndrome (IBS) Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Bausch Health Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2021–2026)
Figure 48. Allergan Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2021–2026)
Figure 49. Takeda Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2021–2026)
Figure 50. Sucampo Pharmaceuticals (Mallinckrodt) Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2021–2026)
Figure 51. Sebela Pharmaceuticals Inc Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2021–2026)
Figure 52. Astellas Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2021–2026)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Ethylene Oxide (EO) Market Research Report 2026
Jan 17, 26
Global Stem Cells Cryopreservation Equipments Market Research Report 2026
Jan 17, 26
Global Selenium-enriched Yeast Market Research Report 2026
Jan 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232